+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Inhibitory effects of ellagic acid on the direct-acting mutagenicity of aflatoxin B1 in the Salmonella microsuspension assay

Inhibitory effects of ellagic acid on the direct-acting mutagenicity of aflatoxin B1 in the Salmonella microsuspension assay

Mutation Research 398(1-2): 183-187

Ellagic acid (EA) is a phenolic compound that exhibits both antimutagenic and anticarcinogenic activity in a wide range of assays in vitro and in vivo. It occurs naturally in some foods such as strawberries, raspberries, and grapes. In the previous work, we used the Salmonella microsuspension assay to examine the antimutagenicity of EA against the potent mutagen aflatoxin B1 (AFB1) using tester strains TA98 and TA100. Briefly, the microsuspension assay was approximately 10 times more sensitive than the standard Salmonella/microsome (Ames) test in detecting AFB1 mutagenicity, and EA significantly inhibited mutagenicity of all AFB1 doses in both tester strains with the addition of S9. The greatest inhibitory effect of EA on AFB1 mutagenicity occurred when EA and AFB1 were incubated together (with metabolic enzymes). Lower inhibition was apparent when the cells were first incubated with EA followed by a second incubation with AFB1, or when the cells were first incubated with AFB1 followed by a second incubation with EA alone, all with metabolic enzymes. The result of these sequential incubation studies indicates that one mechanism of inhibition could involve the formation of an AFB1-EA chemical complex. In the present study, we further examine the effect of EA on AFB1 mutagenicity, but without the addition of exogenous metabolic enzymes. We report the mutagenicity of AFB1 in the microsuspension assay using TA98 and TA100 without the addition of S9. Neither the concentrations of AFB1 (0.6, 1.2, and 2.4 microg/tube) nor the concentrations of EA (0.3, 1.5, 3, 10, and 20 microg/tube) were toxic to the bacteria. The results indicate that AFB1 is a direct-acting mutagen, and that EA inhibits AFB1 direct-acting mutagenicity.

(PDF emailed within 0-6 h: $19.90)

Accession: 046414928

Download citation: RISBibTeXText

PMID: 9626978

DOI: 10.1016/s0027-5107(97)00245-5

Related references

Antimutagenicity of ellagic acid against aflatoxin B1 in the Salmonella microsuspension assay. Mutation Research 360(1): 15-21, 1996

Analysis of mutagens by the microsuspension mutagenicity assay in Salmonella typhimurium. Iarc Scientific Publications 1993(109): 300-306, 1993

Supercritical fluid chromatography coupled with the Salmonella microsuspension mutagenicity assay. Fresenius' Journal of Analytical Chemistry 344(10-11): 442-446, 1992

Genotoxicity of 5-aminolevulinic and 4,5-dioxovaleric acids in the salmonella/microsuspension mutagenicity assay and SOS chromotest. Environmental and Molecular Mutagenesis 40(1): 63-70, 2002

Microsuspension assay employing salmonella typhimurium yg strains for the evaluation of mutagenicity of indoor airborne particulates. Mutation Research 252(1): 108-109, 1991

Comparison of the Salmonella/microsome microsuspension assay with the new microplate fluctuation protocol for testing the mutagenicity of environmental samples. Environmental and Molecular Mutagenesis 51(1): 31-38, 2010

Highly sensitive mutation assay for mutagenicity monitoring of indoor air using Salmonella typhimurium YG1041 and a microsuspension method. Mutagenesis. 12(5): 373-377, 1997

Ursolic acid inhibits aflatoxin B1-induced mutagenicity in a Salmonella assay system. Biological & Pharmaceutical Bulletin 17(7): 990-992, 1994

A preliminary characterization of the mutagenicity of atmospheric particulate matter collected during sugar cane harvesting using the Salmonella/microsome microsuspension assay. Environmental and Molecular Mutagenesis 49(4): 249-255, 2008

An E coli microsuspension assay for the detection of DNA damage induced by direct-acting agents and promutagens. Environmental Mutagenesis 3(4): 429-444, 1981

The direct mutagenicity of aflatoxin B1 and metabolites to Salmonella typhimurium: structure mutagenicity relationships and mechanisms of action. Research Communications in Chemical Pathology and Pharmacology 57(1): 55-76, 1987

Metabolism of 1-nitropyrene by human, rat, and mouse intestinal flora: mutagenicity of isolated metabolites by direct analysis of HPLC fractions with a microsuspension reverse mutation assay. Journal of Toxicology and Environmental Health 31(3): 179-192, 1990

The mechanism of aflatoxin b 1 direct acting mutagenicity. Environmental Mutagenesis 9(SUPPL 8): 80, 1987

Diverse mutagenicity of methylbenz[c]acridines in the direct Ames' Salmonella mutagenicity assay. Anticancer Research 16(5a): 2837-2841, 1996

Mutagenicity of nitrodibenzopyranones in the Salmonella plate-incorporation and microsuspension assays. Mutation Research. 345(1-2): 1-9, 1995